"Hantzsch-type" dihydropyridine hypotensive agents. 3.
D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000502:physiology; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004558:Electric Stimulation; D006168:Guinea Pigs; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy; D007928:Lethal Dose 50; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010525:Peripheral Nerves / Q000502:physiology; D011725:Pyridines / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D013329:Structure-Activity Relationship
D000959:Antihypertensive Agents; D011725:Pyridines; D006830:Hydralazine